Expression of p16, CD95, CD95L and Helix pomatia agglutinin in relapsing and nonrelapsing very thin melanoma

Fearfield, L.A., Larkin, J.M.G., Rowe, A., A'Hern, R., Fisher, C., Francis, N., Mackie, R., McCann, B., Gore, M.E. and Bunker, C.B. (2007) Expression of p16, CD95, CD95L and Helix pomatia agglutinin in relapsing and nonrelapsing very thin melanoma. British Journal of Dermatology, 156(3), pp. 440-447. (doi: 10.1111/j.1365-2133.2006.07581.x)

Full text not currently available from Enlighten.

Publisher's URL: http://dx.doi.org/10.1111/j.1365-2133.2006.07581.x


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Mackie, Professor Rona
Authors: Fearfield, L.A., Larkin, J.M.G., Rowe, A., A'Hern, R., Fisher, C., Francis, N., Mackie, R., McCann, B., Gore, M.E., and Bunker, C.B.
College/School:College of Medical Veterinary and Life Sciences
Journal Name:British Journal of Dermatology
ISSN:0007-0963

University Staff: Request a correction | Enlighten Editors: Update this record